Arkolith/Insider Trading/SPRO/Form 4

Shukla Sath

CEO and President, DirectorSpero Therapeutics, Inc. (SPRO) · full profile →Form 4 · filed Aug 30, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8K
Net Open-Market Flow
-$8K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 29, 2023Sell(S)4K$1.30$5K573K
Aug 28, 2023Sell(S)2K$1.26$2K577K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-045441) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML